XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 12, 2024
Aug. 02, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jan. 29, 2024
Summary of Significant Accounting Policies [Line Items]                
Inventory write-downs (in Dollars)     $ 16,684 $ 111,220 $ 17,325 $ 116,611    
Research and development costs (in Dollars)     $ 3,095,326 $ 203,872 $ 3,432,508 $ 327,866    
Exercise price per share (in Dollars per share)     $ 0.12   $ 0.12     $ 0.12
60P Australia Pty Ltd [Member] | Geoffrey Dow [Member]                
Summary of Significant Accounting Policies [Line Items]                
Number of common shares issued (in Shares)   904,436            
American Pharmaceutical Distributor [Member]                
Summary of Significant Accounting Policies [Line Items]                
Percentage of accounts receivable     96.00%   96.00%   79.00%  
US Government Accounted [Member]                
Summary of Significant Accounting Policies [Line Items]                
Outstanding accounts receivable percentage             13.00%  
Subsequent Event [Member]                
Summary of Significant Accounting Policies [Line Items]                
Reverse stock split the Company effected a reverse stock split at a ratio of 1:12 (the “Reverse Stock Split”)              
60P Australia Pty Ltd [Member] | Minimum [Member]                
Summary of Significant Accounting Policies [Line Items]                
Ownership percentage   87.53%            
60P Australia Pty Ltd [Member] | Maximum [Member]                
Summary of Significant Accounting Policies [Line Items]                
Ownership percentage   96.61%            
Single Customers One [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage         100.00%      
Single Customers Two [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage         96.00%      
Single Customers Three [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage             92.00%  
Customer One [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage             79.00%  
Customer Two [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage             13.00%  
Receivable [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage     92.00%          
Single Customers Four [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage     3.00%   95.00%      
Significant Customers [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]                
Summary of Significant Accounting Policies [Line Items]                
Concentration risk, percentage     100.00%   100.00%